Skip to main content
. 2020 Apr 21;20:234. doi: 10.1186/s12884-020-02935-7

Table 1.

Characteristics of study participants at enrollment. All data are shown as a number (%) unless otherwise indicated

Characteristic at enrollment Magnesium citrate
(n = 407)
Placebo
(n = 422)
P-value
Mean (SD) maternal age, years 26.9 (5.4) 27.2 (5.8) 0.53
Mean (SD) gestational age at entry, weeks 15.1 (3.6) 15.6 (3.8) 0.05
Lives with partner 211 (51.8) 188 (44.5) 0.04
Completed schooling beyond grade 8 379 (93.3) 388 (91.9) 0.44
Currently employed 221 (54.3) 220 (52.1) 0.53
Alcohol use disorder 8 (2.0) 12 (2.8) 0.41
Current smoker 5 (1.2) 11 (2.6) 0.15
Current illicit drug use 3 (0.7) 5 (1.2) 0.73
Pre-pregnancy body mass index, kg/m2
  < 18.5 13 (3.2) 11 (2.6) 0.89
18.5 to 24.9 162 (39.8) 171 (40.7)
25.0 to 29.9 136 (33.4) 146 (34.8)
  ≥ 30.0 96 (23.6) 92 (21.9)
Pre-pregnancy chronic hypertension 50 (22.1) 60 (24.4) 0.59
Gestational diabetes mellitus in a previous pregnancy 11 (4.9) 18 (7.3) 0.27
Preterm birth in a previous pregnancy 38 (9.6) 38 (9.3) 0.87
Mean (SD) serum magnesium concentration, mg/dL 1.8 (0.2) 1.8 (0.2) 0.94
Serum magnesium deficiency < 1.8 mg/dL 194 (47.9) 219 (52.1) 0.22
Mean (SD) serum creatinine concentration, mg/dL 0.5 (0.2) 0.5 (0.1) 0.80